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TITLE

Pharmacist perception of opioid overuse for ana lgesia in the retail setting.

INTRODUCTION

Opioid analgesics are a class of medications with affinity for receptors in the brain which are
naturally targeted by endogenous opioid peptides to exert neuromodulatory action.' Long
before this target pathway was ever elucidated, ancient cultures had documented use of a
naturally occurring plant deriva tive, opium, which provided the same effects as opioid drugs
today. The active alkaloid constituent of opium is morphine. The human body's equivalents of
these substrates interact with multiple types of opioid receptors which produce the effects
responsible for pain relief. In addition, there are also unwanted side effects including
constipation, emesis, and respiratory depression . Contributing to those undesirable factors,
are receptor-induced responses such as euphoria, tolerance, and physical dependence which
provide a causal link to medication abuse.
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While there have been multiple studies done which evaluate the efficacy of opioids in chronic
pain, that determine the pain relief achieved by opioids versus placebo, and those relating
structural modifications to potency and receptor specificity, an initial literature search of the
relationship of chemical changes to the opioid ring system to overutilization of the analgesics
shows a lack of informat ion. The rate of use among the general public is growing at a rapid
pace, with certain opioid prescriptions experiencing an 800% rise in fill rate over the past
decade alone.' It has been asserted that this class of medications is the most commonly
prescribed in the entire US.' Although that may be true in terms of prescription volume, just
greater than 3% of adults are on chronic opioid therapy for treatment of pain not related to
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malignancies,s with chronic treatment being defined as consecutive usage for greater than

three months time.

NEED FOR THE STUDY

There appears to be a lack of literature on the specific topic of interest, but the focus was to
associate professional judgment in the practice setting to a growing crisis noted in the
aforementioned studies. Since frequent refills may be linked to dependence or diversion,
findings from this study alert physicians and other healthcare providers to make informed
decisions when considering analgesic therapy regimens of the double-edged sword balancing
legislation, prescribing, and dispensing to best serve patients. Created awareness could help
reduce the prevalence of overdose in scheduled analgesics which has been noted and
subsequently reviewed by many other previous clinical studies.'·'
Pharmacists are noted as champions for advocating patient safety, and publicizing this data
would serve the same purpose .

Unfortunately, permission could not be obtained to collect retrospective chart data on actual
patients because of perceived liability. Considering the medications being studied were
controlled in nature and the original objective was to ascertain the potential for opioid abuse
and overuse, the managers in charge of pharmacy records were highly reluctant to allow
participation despite guarantee of anonymity in writing. Instead, the design of the study was
altered to gather information regarding pharmacists' perception pertaining to this class of
medications to gauge the reality of previous reports regarding explosion of opioid prescribing,
abuse, and overdoses.
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STUDY OBJECTIVES
This research will help to answer the question, "do practicing retail pharmacists have any
•

qualms about the state of opioid prescribing, legislation, and usage among the public?" To
help determine if this premise has been satisfied, the null hypothesis would state "pharmacists,
to differing degrees, are comfortable with opioid prescribing, legislation, and usage at
present." If the null hypothesis were true, the research question would serve to alleviate fears
and concerns raised amongst other research . Conversely, the directional hypothesis supported
by this study reads "opioids are rightfully classified as controlled substances in the view of
front-line pharmacists due to their high incidence of early fill requests ."

METHODS
The data for this study was collected d irectly from pharmacists' survey responses in the retail
setting. Those eligible for inclusion in the survey were either employed by a drugstore chain in
Fort Wayne, IN, Indianapolis, IN, or Rockford, IL regions or licensed dispensers in Hardin
County, KY.

The goal return for the study was forty responses, to be equally split between each of the four
areas. While power was not calculated due to conducting a survey as opposed to a
randomized controlled trial, this was theorized to give a rando m assortm ent of answers. The
respondents would represent three separate states; a metropolitan district, two moderate
sized cities, and a small town wou ld be analyzed; and finally it com prises largely chain
participants but small retail independents are also included in the study data .
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A survey was designed for administration to pharmacists to garner information relevant to the
study topic at hand. This was reviewed by Priscilla Ryder, MPH for accuracy and completeness
with her expertise in conducting research. For the portion completed by Keny Craig, Pharm .D.
candidate, a list of pharmacies inside Hardin County, KY was created . Each of these stores
were called to obtain responses from the pharmacist on duty, requiring anywhere from 5-10
minutes of their time. Josh Winebaugh, Pharm .D. candidate, received consent from chain
drugstore district managers to distribute a link to Survey Monkey which enabled collection of
responses from a diverse range of locations. Although the setup allowed for multiple choice
responses for simplicity, some of which were Likert scale, there was ample opportunity to
provide additional feedback in the form of open-ended questions expounding on certain

options, as well as, an all-encompassing comments section to conclude the survey.

"Other" categories were often options in the survey to include all potential answer choices.
Confusion about questions potentially leading to misguided answers was a concern addressed
by devising split administration - part by electronic means and the other via telephone with

provision of assistance. Electronic means was a trusted, online survey administration site
versus the discussion of questions with the responding pharmacist through a phone call. Even
offering assistance and additional meaning to questions could be considered "interpretative"
and therefore biased . Despite not having a perfect scenario to elicit this information, efforts
were made to minimize potential threats to study validity.

In order to provide adequate background and properly define terms, "narcotics" were
intended to mean C-II (controlled class 2) opioids versus "other controlled" wh ich would
compri se C-III through C-V (controlled classes 3-5) primarily because of differing legislation
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between groups . KASPER, INSPECT, and PIL are online reporting systems maintained by
individual state boards of pharmacy which compile controlled prescription fill data through use
of social security number and/or driver's license to provide unique patient identifiers in an
attempt to minimize fraud through use of aliases.

Survey Monkey assembled all electronic record s created by the online participants'. Josh
Winebaugh, later compiled the additional results from the Kentucky arm of the study for a
complete statistical analysis and compilation of the solicited feedback other than the directed
twelve questions.

Since there may be potential value in the initial design for conducting a retro spective chart
review, the proposed data collection sheet is still included as Appendix A. The survey
questionnaire is listed in Appendix B.

STATI STICAL ANALYSIS
The multiple choice responses limit the extent of statistical analysis beyond simple percentage
component brea kdowns. Subgroup analysis is completed for telephone survey versus
electronic admini stration as well as Illinois-indiana-Kentucky cohorts and provided in chart
format for ease of review. Differences mayor may not be uncovered to varying degrees and
significance will be assessed ba sed on the discrepancies noticed . The intrigue of variations
between subgroups relate to true deviations in practice between areas, possi bly different
tra ining, altered patient populations, or may suggest the presence/a bsence of overuse and
abuse in the given group of interest.
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RESULTS
The study in all generated forty-seven data sets. Of these : three were from Rockford, IL (6%),
eight from Fort Wayne, IN (17%), nine from Indianapolis, IN (19%), and thirteen from Hardin
County, KY (28%). The remaining fourteen electronic respondents selected " other" for area of
practice accounting for the last 30% [Table 1).

Table 1 - Participant Demographics
Pl ace of Practice
Kentucky
Fort Wayne
Indianapolis
Rockford
Other

Num ber of Participants
13

8
9
3
14

Most pharmacists suggested CII "narcotics" were less likely to be abused (19%) than other
types of controlled opioids (45%), with 36% attributing equivalent potential for overuse [Figure
1). But when asked which category typically filled earlier, the majority (62%) assessed no
difference. 64% of those surveyed communicated that they denied a patient' s refill request
due to early utilization less than 20% of the time [Figure 3) . Over two-thirds of pharmacists
(68%) stated that customers used a mix of cash and prescription coverage (state funded
Medicare/Medica id, insurance, discount programs, etc.) to fund their prescription cost. The
majority of feedback generated noted that customers termed 'abusers' paid with cash, though
this only accounted for 19% of answers overall. The remaining 13% cited a mixture of both
opt ions [Figure 2) . All three states where pharmacists were interviewed offer an online
database with the specific purpose of listing controlled substance fills, although nearly half
(49%) of pha rmacists used the resource monthly or less often [Figure 4). Despite the lack of
use ascribed above, 68% of pharmacists felt somewhat comfortable or neutral with concern to
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ease of use for these systems IFigure 5) . Over half of those completing the survey (57%)
indicated they encountered out-of-state controlled prescriptions more often than monthly
IFigure 6) . When it came to encountering out-of-state prescriptions for controlled substances,
the most common state of origin wa s Ohio (40% of all pharmacists surveyed encountered
prescript ions from th is state) IFigure 8) . Of all pharmacists surveyed, 68% were either neutral
or somewhat uncomfortable due to prescribing practices and patterns coupled with legislation
regard ing opioids (Figure 11). Without hesi tation, 77% stated " refill too soon" was the primary
rejection in denying a fill for one of the se medications IFigure 7) .

Figure 1 - Que st ion 1

8

Figure 2 - Question 2
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Figure 10 - Question 10 (For those patients qualifying Question 9, which is filled earlier?)

• Narcotic Filled Earlier

• Other Controlled Medication Filled Earlier

No Difference

29

# of

responses

10

8

controlled class filled earlier

Figure 11 - Question 11

-

20

• Very Uncomfortable

18
16
14

• Somewhat
Uncomfortable
• Neither Comfortab le nor
Uncomfortable

.-----, 12
# of

res ponses

10

• Somewhat Comfortable

: 1~ __

• Very Comfortable

4

• Unsure

2
degree of comfort wi th legislation and prescribing pattern s

13

Analyzing subgroups with regards to the use of the electronic databases: Kentucky respondents,
8% were very comfortable, 54% were somewhat comfortable, 30% were neither comfortable
nor uncomfortable, and 8% were somewhat uncomfortable using their system. Of Indianapolis
pharmacists, 11% were somewhat comfortable, 56% were neither comfortable nor
uncomfortable, and 33% were somewhat uncomfortable. Of Fort Wayne practitioners, 12%
we re somewhat comfortable, 50% were neither comfortable nor uncomfortable, and 38 % were
somewhat uncomfortable. Of Rockford's licensed professionals, all three (100%) were very
comfortable. Of responses self titled as other, 14% were very comfortable, 36% were somewhat
comfortable, 36% were neither comfortable nor uncomfortable, and 14% were somewhat
uncomfortable [Table 2] .

-

Table 2 Database Ease Subgroup Analysis
Place of Practice

Very
Comfortable

Somewhat
Comfortable

Somewhat
Uncomfortable

Neithe r
Comfortable nor
Uncomfortable

Kentucky (n =13)

1

7

1

4

Indianapolis In = 9)

0

1

3

5

Fort Wayne In = 8)
Rockford In = 3)

0
3

1

3

4

0

0

0

Other In = 14)

2

5

2

5

DISCUSSION
Many offered that the database resources are not managed in real-time and only helps to
determine past trends since there is often a two week lag in reporting. This feedback lends
itself to improvement in the speed processing of controlled substances into the database
yielding better utility and value to pharmacists in practice. Some pharmacists stated they were
not given access to these databases by their employer and expressed their disa ppointment
over this fact as well as rea sons why they believed they weren't granted access. Most
14

prominent among those proposed rationales was the assumption by management team of
increased liability through access to the system if patient fills were not being validated on a

consistent basis.

While out-of-state prescriptions were often cited in previous research literature as being a
tremendous source of abuse, perhaps awareness is to the point where frequency is declining.
The reduction in being presented out-of-state opioid prescriptions was attributed to the
awareness created by communication from state boards of pharmacy which proves the success
of their correspondence. Once pharmacists gained knowledge of the problem, strategies and
policies were implemented to create ways to manage their encounter. Some pharmacists did
offer comment that many of those out-of-state prescriptions presently seen were in fact
legitimate from medical centers or specialty treatments as opposed to the prescription mills
which are sensationalized in the media.

STUDY LIMITATIONS
One of the most limiting parameters in looking at the utilization of controlled substances is
regulation by the FDA. The governmental examination into a new chemical entity determines
its potential for abuse, and is therefore is classified with potential for overuse, thereby alerting
pharmacists to restrict the dispensing the respective medications 'too early.' While this
evaluation is up to the pharmacist's personal discretion or company policy, it inhibits the ability
to study the true overuse in some patients. Another potential limitation will be an
independent pharmacy's inability to link other prescriptions filled elsewhere by a particular
patient, which may (depending on the patient) underestimate their utilization. Distortion of
reality, unintentionally by the pharmacist, may exaggerate in either direction the responses
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generated. As mentioned previously there is contradictory bias between potential for

confusing electronic questions and guiding pharmacists to achieve desired answers when
conducting telephone interview. Another limitation is the minimal amount of specific patient
data available (race, diagnosis code, etc.) which tend to be hallmark for classic studies. Since
there will be no randomized patient selection in the data collection process, unintentional

selection bias may exist.

CONCLUSION
General experience in the retail setting does not make much of this study's findings a shock. At
the same time, quantifying data and gathering feedback from professionals who deal with
issues on a daily basis is perhaps the most apt route for generating change in areas of concern .
Therefore, realizing the repetitive undertone behind many of the responses, especially outside
of the multiple choice, underscores the harsh reality of the widespread phenomenon
previously described in other studies. This study further attests to t he growing epidemic which
is blurring the line of treating pain, the fifth vital sign, and ethics of concern for the general
wellbeing of patients whom pharmacists vow to serve.

What this study does achieve is it offers constructive suggestions for corrective avenues. Two
of the most definitive ways to curb practice and initiate reform would be restructure online
databases and enable pharmacists to share information electronically to their peers about outof-state trends. If significa nt fu nding were provided - perhaps by the same companies which
manufacture opioids - to allow pharmacies to transmit data real-time to the state databases,
there would be a true value to checking them frequently for concerns of opioid overuse with
regard to polypharmacy and drug diversion. Concerns about patient privacy are legitimate and
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thus the need for tremendous funding . The other possibility rests in communication between
pharmacies, chains, or even individual pharmacists to alert peers of trends in out-of-state
prescriptions. Early recognition of suspicious orders would greatly reduce incidence of filling
prescriptions of questionable legality through dissemination of experience information.
Communications was cited in the survey by pharmacists as being beneficial to help reduce
frequency of out-of-state encounters and could continue moving forward to prevent future

occurrences. Once again, realistic privacy issues are present and care must be exercised not to
provide any HIPAA linking information in these proposed alerts. A recommendation not based
directly on findings would be to resort back to the previous study design idea. Even though
access was not obtained for the original study design, there may be tremendous value in
following up with a retrospective chart review to objectively determine the true extent, and
not solely perception, of the issues being described above. The associated data collection tool
is therefore included in Appendix A.

STUDY SIGNIFICANCE
The information collected will, if successful, gauge the reality of concerns stated in previous
research which asserts a growing trend for opioid prescribing and patient practices related to
it. Linking the severity of opioid overuse to drug fill patterns may enable physicians and
pharmacists to collaborate in order to best serve patients in both relieving their pain while

preventing overdose events, including severe constipation, respiratory depression, and even
death . This is most applicable to situations of chronic pain in which patients need analgesia for
greater than three months duration.

17

SCHEDULE
•

Initial research of primary literature / gather background information relevant to top ic --

> February 12, 2010
•

Development of thes is proposal rough draft --> February 19, 2010

•

Thesis proposal submitted to JH 212C --> March 4, 2010

•

Abstract rough draft for poster presentation to faculty mentor --> October 1, 2010

•

Poster rough draft --> October 11, 2010

•

Submit poster presentation abstract to Blackboard's digita l drop box --> October 15,
2010

•

Present poster on campu s in Re illy Room --> October 28, 2010

•

Final submission (and approval) of IRB packet --> November 11, 2010

•

Collect data during Block 8 (rotational month off) --> November 20, 2010-January 2,2011

•

Complete dat a analysis during Blocks 10 and 11 --> January 29-March 25, 2011

•

Submit presentation abstract to Blackboard's digital drop box + register URC abstract -->
February 3, 2011

•

Thesis rough draft due to Dr. Beck --> March 18, 2011

•

Present study find ings at URC on campu s --> April 15, 2011 (l1AM in PB204)

PRESENTATION
Thi s study was prese nted twi ce during th e students' final academic year. In the fall of 2010,
the rough concept was presented to pharmacy coll eagu es on campus via a poster pre sentation
in October. In the spring of 2011, the entirety of the find ings were presented aga in on campu s
but to an open audi ence publicizing the research done in Apri l at an undergraduate research
forum . After f inal subm ission, publicat ion into the Honors th esis col lection w ill ta ke pl ace for
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display in Irwin Library at Butler University. This will make the work universally available for
interlibrary loan, which potentially can be util ized by other universities and experts (as
evidenced from past Honors theses) for future work in the field .
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APPENDIX A
Cod e:

-

Age (at start of study January 1, 2009)'.
Insurer (circl e):
state-funded
private
self-pay
vouchers
Resi dence (circle)
City (Elizabethtown, Radcliff, etc.)
.
Other RX analgesIcs used:
Medication (circle applicable)

morphine

hydromorphone

list month-supply fill date 1
list month-supply fill date 2
list month-supply fill date 3
list month -supply fill date 4

list month-supply fill date 5
list month-supply fill date 6
list month-supply fitl date 7
list month-supply fill date 8
List month-supply fill date 9
List month-supply fill date 10

list month-supply fill date 11
list month -supply fill date 12
list month -supply fill date 13

-,0,+

Difference in days between expected and actual fill
First until second
Second until third
Third until fourth
Fourth until fifth
Fifth until sheth
Sixth unt il seventh
Seventh until eighth
Eighth unt it ninth
Ninth until tenth
Tenth until eleventh
Eleventh until twelfth
Twelfth until thirteenth
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discou nt ca rds

other

Rura l (surround ing areas)

hydrocodone

oxycodone

APPENDIX B
I.

Do you notice more abuse/overuse potential with opioid narcotics (e . g .
oxycodone , morphine , etc . ) or other controlled apioids (e . g .
hydrocodone , tramadol , etc . )?
a.

narcotics

b.

other controlled

c.

equivalent abuse/overuse

2. Do patients seeking these types of medications tend to use prescription
coverage (e . g . third party insurance . discount programs ,
Medicaid/Medicare) , choose to pay cash , or both?
a.

prescription coverage

b.

cash

c.

both

3 . How often , as a percentage estimate , do you have to deny patients '
access to fill/refill their pain management prescriptions due to early
uti11zation attempts?

4 . How often do you typically use KASPR (Kentucky ' s version) , INSPECT
(Indiana ' s version) , or PIL (Illinois ' version) to inquire about patients
records?
a.

daily or more frequently

b.

weekly

c.

monthly or less frequently

d.

other

5 . Do you feel comfortable using the KASPR , INSPECT , or PIL system and what
recommendations could you make to improve its usability?
a . very comfortable
b . somewhat comfortable
c . neither comfortable nor uncomfortable
d . somewhat uncomfortable
Comments :
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6 . How often do you encounter out - of-state controlled
prescriptions?
a . daily or more frequently
b . weekly
c . monthly or less frequently
d . other
7 . When you ' re forced to deny filling a pa1n management
prescription , what is the usual cause?
a.

refill too soon

b.

failure to produce 1D

C.

out of state origin

d.

prescription dating issues (expired , post - dated , etc . )

e.

therapeutic duplication

f.

other

8 . What states other than the one 1n which yo practice do you
encounter controlled substance prescriptions from?

9 . Approx imately what percentage of patients use both a narcotic
and another controlled opioid prescription for pain management?

10 . From the last question , do you notice patients trying to fill
one of the two earlier than the other?

a . narcotic
b.

con trolled

C.

no difference
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11. Do you feel put into a difficult situation by prescribing
patterns/practices and legislation governing these medications?
a.

very uncomfortable

b.

somewhat uncomfortable

C.

neither comfortable nor uncomfortable

d.

somewhat comfortable

e.

very comfortable

f.

unsure

12 . Are there any other pertinent comments you would like to
include for this study?
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